The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
Open accessAbstract
Uncertainty regarding pathogenic mechanisms has been a major impediment to effective prevention and treatment for human neurologic diseases such as multiple sclerosis, tropical spastic paraparesis, and AIDS demyelinating disease. Here, we implicate lymphotoxin (LT) (tumor necrosis factor beta [TNF-beta]) and TNF-alpha in experimental allergic encephalomyelitis (EAE), a murine model of an autoimmune demyelinating disease. In this communication, we report that treatment of recipient mice with an antibody that neutralizes LT and TNF-alpha prevents transfer of clone-mediated EAE. LNC-8, a myelin basic protein-specific T cell line, produces high levels of LT and TNF-alpha after activation by concanavalin A, antibody to the CD-3 epsilon component of the T cell receptor, or myelin basic protein presented in the context of syngeneic spleen cells. LNC-8 cells transfer clinical signs of EAE. When LNC-8 recipient mice were also treated with TN3.19.12, a monoclonal antibody that neutralizes LT and TNF-alpha, the severity of the transferred EAE was reduced, while control antibodies did not alter the disease. The effect of anti-LT/TNF-alpha treatment was long lived and has been sustained for 5 mo. These findings suggest that LT and TNF-alpha and the T cells that produce them play an important role in EAE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., & Cerami, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1670 · Cited by 1,516
The Brain in AIDS: Central Nervous System HIV-1 Infection and AIDS Dementia Complex
Price, R. W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A. C., & Cleary, P. (1988) · Science · doi:10.1126/science.3277272 · Cited by 1,245
Molecular cloning and expression of a receptor for human tumor necrosis factor
Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90816-w · Cited by 964
ACHAORBEA, H. (1988) · Cell · doi:10.1016/0092-8674(88)90558-2 · Cited by 925
Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
Loetscher, H., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., Tabuchi, H., & Lesslauer, W. (1990) · Cell · doi:10.1016/0092-8674(90)90815-v · Cited by 905
Tumor necrosis factor identified in multiple sclerosis brain.
Hofman, F. M., Hinton, D. R., Johnson, K., & Merrill, J. E. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.607 · Cited by 801
Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral Malaria
Grau, G. E., Fajardo, L. F., Piguet, P.-F., Allet, B., Lambert, P.-H., & Vassalli, P. (1987) · Science · doi:10.1126/science.3306918 · Cited by 736
Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
Ohara, J., & Paul, W. E. (1985) · Nature · doi:10.1038/315333a0 · Cited by 726
Cited by
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,341
Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
Liblau, R. S., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,105
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al. (1994) · Science · doi:10.1126/science.8171322 · Cited by 986
Self-citationMICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835
Self-citationThe adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 763
The role of microglia and macrophages in the pathophysiology of the CNS
Stollg, G., & Jander, S. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00083-5 · Cited by 683
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 658
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., & Röcken, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1961 · Cited by 594
Koni, P. A., Sacca, R., Lawton, P., Browning, J. L., Ruddle, N. H., & Flavell, R. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80292-7 · Cited by 589
Self-citationTNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 533
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 495
CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death
Louis, J.-C., Magal, E., Takayama, S., & Varon, S. (1993) · Science · doi:10.1126/science.8430320 · Cited by 486
Steinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479
BROWNING, J. (1993) · Cell · doi:10.1016/0092-8674(93)90574-a · Cited by 475
Interferon‐γ confers resistance to experimental allergic encephalomyelitis
Krakowski, M., & Owens, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260735 · Cited by 471
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B. M., Dwyer, B. K., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 469
The experimental autoimmune encephalomyelitis (EAE) model of MS
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00008-x · Cited by 464
Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
Selmaj, K., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 436
Chronic inflammation caused by lymphotoxin is lymphoid neogenesis.
Kratz, A., Campos-Neto, A., Hanson, M. S., & Ruddle, N. H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1461 · Cited by 431
Self-citationLafaille, J. J., Keere, F. V. D., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426
Cytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F., & Coffman, R. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90044-l · Cited by 408
Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G., & Kollias, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11294 · Cited by 403
Experimental Autoimmune Encephalomyelitis in the Mouse
Miller, S. D., & Karpus, W. J. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1501s77 · Cited by 401
Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., & Tilton, R. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117282 · Cited by 384
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
Martin, R., McFarland, H. F., & Boggs, J. M. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084683 · Cited by 376
Angeles Muñoz-Fernández, M., & Fresno, M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00045-8 · Cited by 367
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Chemokine expression in murine experimental allergic encephalomyelitis
Godiska, R., Chantry, D., Dietsch, G. N., & Gray, P. W. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00008-p · Cited by 353
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
Sommer, N., Löschmann, P.-A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., et al. (1995) · Nature Medicine · doi:10.1038/nm0395-244 · Cited by 345
Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., Helwig, A., & Poser, S. (1995) · Annals of Neurology · doi:10.1002/ana.410370115 · Cited by 334
CNS Demyelination with TNF-α Blockers
Kemanetzoglou, E., & Andreadou, E. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0742-1 · Cited by 319
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., & Probert, L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65622-2 · Cited by 316
Robinson, W. H., Genovese, M. C., & Moreland, L. W. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<1977::aid-art345>3.0.co;2-6 · Cited by 310
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
Soong, L., Xu, J.-C., Grewal, I. S., Kima, P., Sun, J., Longley, B. J., Ruddle, N. H., McMahon-Pratt, D., & Flavell, R. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80434-3 · Cited by 303
Self-citationYang, X. D., Tisch, R., Singer, S. M., Cao, Z. A., Liblau, R. S., Schreiber, R. D., & McDevitt, H. O. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.995 · Cited by 303
Astrocytes—Friends or foes in multiple sclerosis?
Williams, A., Piaton, G., & Lubetzki, C. (2007) · Glia · doi:10.1002/glia.20546 · Cited by 302
Hunter, Z., McCarthy, D. P., Yap, W. T., Harp, C. T., Getts, D. R., Shea, L. D., & Miller, S. D. (2014) · ACS Nano · doi:10.1021/nn405033r · Cited by 301
Adhesion molecule expression and regulation on cells of the central nervous system
Lee, S. J., & Benveniste, E. N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00084-3 · Cited by 296
Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R., & Hofman, F. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.574 · Cited by 297
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease
Miller, S. D., Turley, D. M., & Podojil, J. R. (2007) · Nature Reviews Immunology · doi:10.1038/nri2153 · Cited by 290
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1573 · Cited by 287
Raine, C. S., Cannella, B., Hauser, S. L., & Genain, C. P. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<144::aid-ana3>3.0.co;2-k · Cited by 286
The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion
Raine, C. S. (1994) · Annals of Neurology · doi:10.1002/ana.410360716 · Cited by 285
Buonaguro, L., Barillari, G., Chang, H. K., Bohan, C. A., Kao, V, Morgan, R., Gallo, R. C., & Ensoli, B. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7159-7167.1992 · Cited by 277
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis
Steinman, L., & Zamvil, S. S. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.014 · Cited by 265
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01315.x · Cited by 263
Interferon β decreases T cell activation and interferon γ production in multiple sclerosis
Noronha, A., Toscas, A., & Jensen, M. A. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90244-s · Cited by 261
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., & Feldmann, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390318 · Cited by 261
Ito, A., Bebo, B. F., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A., & Offner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.542 · Cited by 254
Female sex steroids: effects upon microglial cell activation
Drew, P. D., & Chavis, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00386-6 · Cited by 209
“The estrogenic steroids inhibition of the synthesis of these molecules blocks estriol and b-estradiol, as well as progesterone, inhibited development of EAE (Ruddle et al., 1990; Selmaj et al., TNF-a elicited from these cells, as determined by ELISA 1991; Zhou et al., 1996; Ding et al., 1998).”
BackgroundMadsen, P. M., Motti, D., Karmally, S., Szymkowski, D. E., Lambertsen, K. L., Bethea, J. R., & Brambilla, R. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0211-16.2016 · Cited by 161
MILLER, S. D., McMAHON, E. J., SCHREINER, B., & BAILEY, S. L. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.023 · Cited by 144
Kallmann, B. A. (2000) · Brain · doi:10.1093/brain/123.4.687 · Cited by 106
Experimental models of multiple sclerosis
Pachner, A. R. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328346c226 · Cited by 90
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
Delbridge, A. R. D., Huh, D., Brickelmaier, M., Burns, J. C., Roberts, C., Challa, R., Raymond, N., Cullen, P., Carlile, T. M., Ennis, K. A., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592005 · Cited by 72
Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination
Plant, S. R., Arnett, H. A., & Ting, J. P. (2005) · Glia · doi:10.1002/glia.20089 · Cited by 60
Bebo, B. F., & Linthicum, D. S. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00113-5 · Cited by 51
Plant, S. R., Iocca, H. A., Wang, Y., Thrash, J. C., O'Connor, B. P., Arnett, H. A., Fu, Y.-X., Carson, M. J., & Ting, J. P.-Y. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1307-07.2007 · Cited by 51
Experimental encephalomyocarditis virus infection in small laboratory rodents
Doi, K. (2011) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2010.05.001 · Cited by 26
Sex Steroid Regulation of Microglial Cell Activation: Relevance to Multiple Sclerosis
DREW, P. D., CHAVIS, J. A., & BHATT, R. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.031 · Cited by 25
The induction of renal autoantigen-specific T cells by a local Listeria monocytogenes infection.
(1995) · PubMed Central · Cited by 7
Metadata
- Authors
- Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1990-10-01
- Volume
- 172
- Issue
- 4
- Pages
- 1193-1200
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2109577352
- Cited by
- 688
- References
- 22
- FWCI
- 28.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.